Does Dr. AUTUMN ADAMS have financial conflicts of interest?

Dr. AUTUMN ADAMS (O.D.) has received a total of $566 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $566 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. AUTUMN ADAMS?

According to CMS Open Payments data, Dr. AUTUMN ADAMS received funding from SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US ($162), JOHNSON & JOHNSON VISION CARE ($131), and BAUSCH & LOMB AMERICAS ($130).

Does Dr. AUTUMN ADAMS receive research grants or speaking fees?

Dr. AUTUMN ADAMS has received $566 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. AUTUMN ADAMS

O.D.Real-Time Hydrated

Specialty: Optometrist

Practice Location: CABOT, AR 72023

NPI Number: 1649653007

LIFETIME INDUSTRY VALUE

$566

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ADAMS is a verified Optometrist practitioner based in CABOT, AR.

Between 2021 and 2025, Dr. ADAMS had an overall industry promotional and research financial footprint of $566 as recorded in the federal CMS Open Payments database.

$566 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADAMS's primary funding source is SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, which accounts for $162 (representing 28.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US

Rank 1

$162

28.6%

JOHNSON & JOHNSON VISION CARE

Rank 2

$131

23.2%

BAUSCH & LOMB AMERICAS

Rank 3

$130

23%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.